<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Encounter Summary</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">William Yetto</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">November 16, 1949 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Unknown</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Unknown</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>7637 Greystone Dr.<br/>Hudson, FL 34667, USA<br/>Effective Date: May 22, 2024 <br/><br/> Previous Address:<br/>7637 Graystone Dr.<br/>Hudson, FL 34667, USA<br/>Effective Date: May 8, 2024 <br/>Expiration Date: May 21, 2024 <br/><br/>Primary Home Phone:  +1-617-899-5345<br/>Email:  wy2050@verizon.net<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">TGHMXGX5F2RDRFZ 1.2.840.114350.1.13.259.2.7.3.688884.100<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value"> 1.2.840.114350.1.13.259.2.7.8.688883.440347285</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">September 11, 2024, 17:06:59 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Chirag Patel,  MD of HERNANDO PASCO PRIMARY CARE LLC</td></tr><tr><td class="td_header_role_value internal_format"> Work Address:<br/>13906 LAKESHORE BLVD<br/>STE 330<br/>HUDSON, FL 34667, USA<br/><br/>Work Phone:  +1-727-863-5242<br/>Fax:  +1-727-862-8510<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Kevin S Spires,  MD of SUNCOAST UROLOGY PA</td></tr><tr><td class="td_header_role_value internal_format"> Work Address:<br/>7614 JACQUE RD<br/>STE A<br/>HUDSON, FL 34667, USA<br/><br/>Work Phone:  +1-727-862-8548<br/>Fax:  +1-727-863-4530<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">Epic - Version 10.9</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">193926354 1.2.840.114350.1.13.259.2.7.3.698084.8</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">Telemedicine</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From May 21, 2024, 16:30:00 -0400  to May 23, 2024, 10:41:45 -0400 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">Cancer Center of South Tampa of </td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Alexander Engelman of Tampa General Hospital</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>601 S ARMENIA AVE<br/>TAMPA, FL 33609, USA<br/><br/>Work Phone:  +1-813-353-8803<br/>Fax:  +1-813-353-8602<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Manager Him signed at September 11, 2024, 17:06:59 -0400 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Tampa General Hospital</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Work Address:<br/>1 Tampa General Circle<br/>Tampa, FL 33606, USA<br/><br/><br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Visit</a></li><li><a href="#id2">Encounter Details</a></li><li><a href="#id3">Social History</a></li><li><a href="#id4">Progress Notes</a></li><li><a href="#id5">Plan of Treatment</a></li><li><a href="#id6">Visit Diagnoses</a></li><li><a href="#id7">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv2"><td ID="reasonrfv2">Prostate Cancer</td><td/></tr></tbody></table></li><li>Other (Routine) - Closed: <table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td>Radiation Oncology</td><td><p>Diagnoses</p><p>Malignant neoplasm of prostate (HC CODE)</p><br/><p>Procedures</p><p>G2211</p></td><td><p>Patel, Chirag, MD</p><p>13906 LAKESHORE BLVD</p><p>STE 330</p><p>HUDSON, FL 34667</p><p>Phone: tel:+1-727-863-5242</p><p>fax:+1-727-862-8510</p></td><td><p>Engelman, Alexander, MD</p><p>601 S ARMENIA AVE</p><p>TAMPA, FL 33609</p><p>Phone: tel:+1-813-353-8803</p><p>fax:+1-813-353-8602</p></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>10931628</td><td class="xflagData">Closed</td><td/><td>5/21/2024</td><td>8/18/2024</td><td>1</td><td>1</td></tr></tbody></table><br/></li></ul></div><h3><a name="id2" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter4" class="xRowNormal"><td>05/21/2024  4:30 PM EDT</td><td ID="encounter4type">Telemedicine</td><td><p>Cancer Center of South Tampa</p><p>601 S. Armenia Ave.</p><p>Tampa, FL 33609</p><p>813-353-8803</p></td><td><p>Engelman, Alexander, MD</p><p>601 S ARMENIA AVE</p><p>TAMPA, FL 33609</p><p>813-353-8803 (Work)</p><p>813-353-8602 (Fax)</p></td><td><content>Malignant neoplasm of prostate (HC CODE) (Primary Dx); <br/>PSA elevation; <br/>Secondary malignant neoplasm of bone (HC CODE); <br/>Prostate cancer metastatic to intrapelvic lymph node (HC CODE)</content></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Social History</a></h3><div><table ID="sochist12"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never Assessed</td><td/><td ID="sochist12packsperday"/><td/><td/></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex15"><td>Sex Assigned at Birth</td><td ID="BirthSex15Value">Not on file</td><td/></tr><tr ID="LegalSex16"><td>Legal Sex</td><td ID="LegalSex16Value">Male</td><td>12/20/2023  2:06 PM EST</td></tr><tr ID="GenderIdentity13"><td>Gender Identity</td><td ID="GenderIdentity13Value">Not on file</td><td/></tr><tr ID="SexualOrientation14"><td>Sexual Orientation</td><td ID="SexualOrientation14Value">Not on file</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id4" href="#toc">Progress Notes</a></h3><div><ul><li>Alexander Engelman, MD - 05/21/2024  4:30 PM EDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>Patient Name:  William Yetto<br/>Date of Birth:    11/16/1949<br/>Medical Record:  101632979<br/>Encounter Date:  5/21/2024 <br/> <br/>Subjective:<br/><br/>Chief Complaint: The patient is a 74 y.o. male who presents with mCSPC on presentation<br/><br/>- 03/14/2024 TURP: Pathology: Prostatic adenocarcinoma, grade 4 + 5 = 9 occupying approximately 50% of submitted tissue. <br/><br/>- iPSA 1,953<br/><br/>- 05/03/2024 PSMA PET (Akumin): Enlargement of the prostate gland with heterogeneous intense radiotracer uptake in the parenchyma (SUV MAX 37.4) representing biopsy proven cancer. Extracapsular extension of the tumor with possible infiltration of the rectum. Left subcentimeter external iliac metastatic lymph nodes with SUV max of 16.1. Innumerable avid bone lesions in skull base, axial skeleton, and bilateral proximal femurs representing metastatic bone disease. Hyperdense and heterogeneous masses in the retromandibular regions bilaterally measuring 5.6 cm on the right and 8.8 cm on the left, indeterminate. Neck MRI without and with contrast is recommended for better characterization.<br/><br/>- Ongoing Eligard (Start 05/2024)<br/>HPI: <br/>Mr. Yetto is a 74 year old man with prostate cancer. He has a personal medical history of HTN, HLD, urine retention, GERD, gout, COPD, and Barrett's esophagus. <br/><br/>He is followed by Dr. Spires at Suncoast Urology. DRE: 50 g and Benign. <br/><br/>10/03/2023 CT A/P (HCA Bayonet Point): Moderate bilateral hydronephrosis secondary due to massive urinary bladder dilation abouve the level of the umbilicus. Bladder outlet obstruction could be present. Prosatomegaly. <br/><br/>10/03/2023<br/><br/>01/17/2024 TRUS: Moderate prostatomegaly<br/><br/>03/14/2024 TURP: Pathology: Prostatic adenocarcinoma, grade 4 + 5 = 9 occupying approximately 50% of submitted tissue. <br/><br/>04/09/2024 PSA: 1,953.0, Alk phos: 175 (H), Hgb: 11.8 (L), Hct: 35.7 (L)<br/><br/>05/03/2024 PSMA PET (Akumin): Enlargement of the prostate gland with heterogeneous intense radiotracer uptake in the parenchyma (SUV MAX 37.4) representing biopsy proven cancer. Extracapsular extension of the tumor with possible infiltration of the rectum. Left subcentimeter external iliac metastatic lymph nodes with SUV max of 16.1. Innumerable avid bone lesions in skull base, axial skeleton, and bilateral proximal femurs representing metastatic bone disease. Hyperdense and heterogeneous masses in the retromandibular regions bilaterally measuring 5.6 cm on the right and 8.8 cm on the left, indeterminate. Neck MRI without and with contrast is recommended for better characterization.<br/><br/>05/16/2024 Eligard 22.5 mg<br/><br/>Mr. Yetto presents today via telehealth. <br/><br/> <br/><br/>Past Medical History:  <br/>No past medical history on file. <br/><br/>Surgical History:  <br/>No past surgical history on file.<br/><br/>Family History:  His family history is not on file.<br/><br/>Social History: He  <br/><br/>Tobacco History: He  has no history on file for tobacco use.<br/><br/>Allergies: William has no allergies on file. <br/><br/>Medications:<br/>No current outpatient medications on file. <br/>Labs: <br/>Labs in Last 3 Months No results found for this or any previous visit (from the past 2232 hour(s)).<br/> <br/> Objective:<br/>Vital signs: There were no vitals taken for this visit. <br/><br/>Physical Exam: <br/><br/>Constitutional:  <br/>   Normal appearance.  <br/>Pulmonary: <br/>   Normal respiratory effort. <br/>Psychiatric:    <br/>   Normal mood and affect. <br/>Physical Exam <br/><br/>In House Urinalysis: <br/>No results found for this or any previous visit. <br/><br/>Data Reviewed: <br/>Data reviewed during this visit:  Labs, Radiology reports, Radiology images, and Consult notes<br/>  <br/>Assessment:<br/>1. Malignant neoplasm of prostate (HC CODE)  <br/><br/>None<br/><br/>Plan:<br/>Continue on Eligard. <br/><br/>With mCSPC, secondary androgen agent indicated. Erleada Rx sent to FLUP pharmacy today and benefit investigation is underway. We will arrange for him to pick up at Dr. Spires' office. <br/><br/>We discussed the indication for docetaxel but he does not want to pursue chemotherapy at this time.<br/><br/>Alendronate sent to his pharmacy today. Calcium and vit D supplementation also encouraged for bone health while on combined androgen blockade. <br/><br/>RTC in 08/2024 with new PSA/CMP/TST to assess response.<br/>Orders Placed This Encounter <br/> COMPREHENSIVE METABOLIC PANEL (CMP), SERUM <br/> PROSTATE SPECIFIC ANTIGEN (PSA) <br/> TESTOSTERONE, FREE, TOTAL <br/> apalutamide (Erleada) 240 mg Tab <br/> alendronate (FOSAMAX) 70 mg tablet <br/>We reviewed his medical history and clinical course to date. I discussed the risk stratification, prognosis, and management options for prostate cancer as well as my partnership with Dr. Spires within Florida Urology Partners.  We discussed treatment options, including: chemotherapy, surgery and radiation therapy +/- hormone therapy and secondary androgen agent.  Expectations, risks and side effects reviewed. <br/> <br/></content><br/><span class="xLabel">Electronically signed by Alexander Engelman, MD at 05/22/2024  1:39 PM EDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id5" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Scheduled Orders</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Order Schedule</th></tr></thead><tbody><tr ID="procedure36"><td><span class="content_span">COMPREHENSIVE METABOLIC PANEL (CMP), SERUM</span></td><td>Lab</td><td>Routine</td><td><p>Malignant neoplasm of prostate (HC CODE)</p><p>PSA elevation</p><p>Secondary malignant neoplasm of bone (HC CODE)</p><p>Prostate cancer metastatic to intrapelvic lymph node (HC CODE)</p></td><td ID="procedure36schedule">Expected: 08/22/2024 (Approximate), Expires: 11/18/2024</td></tr><tr ID="procedure37"><td><span class="content_span">PROSTATE SPECIFIC ANTIGEN (PSA)</span></td><td>Lab</td><td>Routine</td><td><p>Malignant neoplasm of prostate (HC CODE)</p><p>PSA elevation</p><p>Secondary malignant neoplasm of bone (HC CODE)</p><p>Prostate cancer metastatic to intrapelvic lymph node (HC CODE)</p></td><td ID="procedure37schedule">Expected: 08/22/2024 (Approximate), Expires: 11/18/2024</td></tr><tr ID="procedure38"><td><span class="content_span">TESTOSTERONE, FREE, TOTAL</span></td><td>Lab</td><td>Routine</td><td><p>Malignant neoplasm of prostate (HC CODE)</p><p>PSA elevation</p><p>Secondary malignant neoplasm of bone (HC CODE)</p><p>Prostate cancer metastatic to intrapelvic lymph node (HC CODE)</p></td><td ID="procedure38schedule">Expected: 08/22/2024 (Approximate), Expires: 11/18/2024</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id6" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx5" class="xRowNormal"><td><p><span class="content_span">Malignant neoplasm of prostate (HC CODE)</span><span class="content_span"> - Primary</span></p><p>Malignant neoplasm of prostate</p></td></tr><tr ID="vdx6" class="xRowAlt"><td><p><span class="content_span">PSA elevation</span></p><p>Elevated prostate specific antigen (PSA)</p></td></tr><tr ID="vdx7" class="xRowNormal"><td><p><span class="content_span">Secondary malignant neoplasm of bone (HC CODE)</span></p><p>Secondary malignant neoplasm of bone and bone marrow</p></td></tr><tr ID="vdx8" class="xRowAlt"><td><p><span class="content_span">Prostate cancer metastatic to intrapelvic lymph node (HC CODE)</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id7" href="#toc">Care Teams</a></h3><div><table ID="ct48"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>Patel, Chirag, MD</p><p>NPI: 1902870819</p><p>13906 LAKESHORE BLVD</p><p>STE 330</p><p>HUDSON, FL 34667</p><p>727-863-5242 (Work)</p><p>727-862-8510 (Fax)</p></td><td>PCP - General</td><td>Internal Medicine</td><td>5/8/24</td><td/></tr><tr class="xRowAlt"><td><p>Spires, Kevin S, MD</p><p>NPI: 1750338885</p><p>7614 JACQUE RD</p><p>STE A</p><p>HUDSON, FL 34667</p><p>727-862-8548 (Work)</p><p>727-863-4530 (Fax)</p></td><td/><td>Urology</td><td>5/8/24</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/></body></html>